Clinical Trials Arena is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Inbrija for the Treatment of OFF Episodes in Parkinson’s Disease

Drug Name

Inbrija™ (levodopa inhalation powder)

Developer

Acorda Therapeutics

Therapy Class

Oral inhalation drug

Product Description

Aromatic amino acid

Current Indication

OFF episodes in Parkinson’s disease patients

Market Sector

CNS

Developmental Status

Approved in the US
Expand
Close
Close
Close

Go Top